Tag: Colonis

November 5, 2015 Off

Quantum Pharma’s Colonis launches medical devices for side effects of cancer treatment

Colonis, part of Quantum Pharma’s newly formed Niche Pharmaceuticals division, has launched its in-licensed range of patented medical devices to treat…

October 12, 2015 Off

Quantum Pharma signs out-licensing deal for Aviticol in Germany

By Dino Mustafić

Quantum Pharma has signed an out-licensing agreement with a German pharmaceutical company for its first licensed product, a cholecalciferol 20 000IU capsule, marketed in the UK under the brand name Aviticol.